Investor Stock List
Ranked #2,849 of 8,699 institutional investors

Silverarc Capital Management, LLC

Boston, MA

$747M
US stock portfolio at live prices · today −$2.2M (−0.29%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$821M
Change from Q2 2026
−$77.6M (−8.63%)
Positions
51 · 11 new, 13 sold out
Filed
Nov 12, 2026

Not counted in the ranking: call options on $30.8M of stock, put options on $2.7M. $139M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
KOD 9.83%CELC 6.05%COGT 5.84%RYTM 5.44%SGMT 4.82%
StockSharesValue, live% of portfoliovs Q2 2026
KOD Kodiak Sciences Inc.750,170$73.4M9.83%Added +37%
CELC Celcuity Inc.803,193$45.2M6.05%Added +60%
COGT Cogent Biosciences, Inc.1,574,698$43.7M5.84%Added +23%
RYTM Rhythm Pharmaceuticals, Inc.348,317$40.7M5.44%Added +12%
SGMT Sagimet Biosciences Inc.3,745,990$36.0M4.82%Added +28%
IMNM Immunome, Inc.2,092,715$34.8M4.65%Added +4%
BIIB Biogen Inc.112,790$27.9M3.73%Added +134%
GLUE Monte Rosa Therapeutics, Inc.3,112,773$27.7M3.71%Added +181%
ORKA Oruka Therapeutics, Inc.247,918$24.2M3.24%Reduced −30%
IMVT Immunovant, Inc.624,055$20.3M2.72%Added +1%
DNTH Dianthus Therapeutics, Inc.236,582$20.1M2.69%Reduced −39%
ERAS Erasca, Inc.1,330,455$18.9M2.53%Added +5%
SYRE Spyre Therapeutics, Inc.151,151$14.8M1.97%Added +152%
ABVX ABIVAX Société Anonyme175,699$14.2M1.90%Added +4%
OVID Ovid Therapeutics Inc.5,950,000$13.9M1.86%Added +92%
CLDX Celldex Therapeutics, Inc.487,589$13.6M1.82%New
AVLN Avalyn Pharma Inc.378,352$10.9M1.45%Added +14%
DFTX Definium Therapeutics, Inc.345,946$10.2M1.36%Reduced −14%
CCCC C4 Therapeutics, Inc.3,454,647$8.4M1.13%Added +14%
ZBIO Zenas BioPharma, Inc.334,057$8.4M1.12%Reduced −34%
SVRA Savara Inc.1,518,833$7.9M1.06%Added +12%
CERS Cerus Corporation3,950,595$7.5M1.00%Added +14%
PCVX Vaxcyte, Inc.125,080$7.3M0.98%Reduced −14%
ALXO ALX Oncology Holdings Inc.6,565,960$6.7M0.90%Added +14%
CMPS COMPASS Pathways plc717,356$6.2M0.83%Added +43%
PRAX Praxis Precision Medicines, Inc.19,753$6.1M0.82%Reduced −70%
ELVN Enliven Therapeutics, Inc.121,452$5.6M0.75%Reduced −75%
SLDB Solid Biosciences Inc.760,337$4.9M0.66%Added +14%
EVMN Evommune Inc594,027$4.3M0.58%New
YARW Yarrow Bioscience, Inc.301,919$4.3M0.57%New
IBIO iBio, Inc.5,357,088$4.3M0.57%Added +52%
BNTC Benitec Biopharma Inc.443,109$3.6M0.48%Reduced −35%
IRON Disc Medicine, Inc.47,312$3.6M0.48%Reduced −43%
ARCT Arcturus Therapeutics Holdings Inc.459,899$3.5M0.47%New
BLSM BlossomHill Therapeutics, Inc.202,104$2.9M0.39%New
SNDX Syndax Pharmaceuticals, Inc.247,418$2.3M0.30%Reduced −80%
PALI Palisade Bio, Inc.2,335,602$2.2M0.29%New
MRNA Moderna, Inc.10,000$2.0M0.27%New
ANL Adlai Nortye Group Ltd.216,617$2.0M0.26%New
ZVRA Zevra Therapeutics, Inc.200,260$1.8M0.24%New
ELUT Elutia Inc.2,192,980$1.8M0.24%Unchanged
ABEO Abeona Therapeutics Inc.693,441$1.7M0.23%Added +14%
TELA TELA Bio, Inc.2,137,201$1.6M0.21%Unchanged
CTNM Contineum Therapeutics, Inc.158,964$1.4M0.19%Reduced −46%
ORIC ORIC Pharmaceuticals, Inc.160,552$1.2M0.17%Reduced −78%
FTH Faeth Therapeutics, Inc.124,098$1.1M0.14%New
QUIT Achieve Life Sciences, Inc.158,950$933K0.12%Reduced −30%
RAPP Rapport Therapeutics, Inc.35,524$838K0.11%New
ACRS Aclaris Therapeutics, Inc.238,541$835K0.11%Reduced −88%
CAMP Camp4 Therapeutics Corp183,063$732K<0.1%Reduced −72%
CLRB Cellectar Biosciences, Inc.151,118$133K<0.1%Reduced −53%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
GH Guardant Health, Inc.99,826$14.5M
MANE Veradermics Inc95,000$11.8M
TRVI Trevi Therapeutics, Inc.678,095$9.3M
VCYT Veracyte, Inc.318,001$8.0M
XENE Xenon Pharmaceuticals Inc.186,821$7.0M
WGS GeneDx Holdings Corp.122,269$6.0M
INSM Insmed Incorporated34,438$5.0M
AVTX Avalo Therapeutics, Inc.500,402$3.4M
ARTV Artiva Biotherapeutics, Inc.525,000$2.0M
RVMD Revolution Medicines, Inc.10,000$1.6M
SION Sionna Therapeutics, Inc.42,478$126K
FHTX Foghorn Therapeutics Inc.45,975$82K
KPTIQ Karyopharm Therapeutics Inc.297,460$10K